Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.
Jay AcharJames A SeddonGwenan M KnightPeter J DoddHanif EsmailJennifer HughesChristopher Finn McQuaidPublished in: The European respiratory journal (2023)